A seizure is a sudden, uncontrolled burst of electrical activity in the brain that can cause changes in behavior, movements, feelings, and levels of consciousness. Epilepsy is a chronic neurological condition characterized by an enduring predisposition to generate unprovoked seizures. A single seizure does not automatically mean a person has epilepsy; diagnosis typically requires at least two unprovoked seizures occurring more than 24 hours apart.
Seizures are broadly split into two main categories:
Status epilepticus is a medical emergency defined as a continuous seizure lasting longer than five minutes or recurrent seizures without full recovery of consciousness between them. Immediate intervention is required to prevent permanent brain damage or death.
Anticonvulsants, also known as anti-epileptic drugs, work by calming the hyperactive electrical discharges in the brain that trigger seizures. They do not cure epilepsy, but they successfully control seizure frequency and intensity. Their primary goal is to stabilize the neuronal membrane and prevent the spread of abnormal electrical signals.
Most anticonvulsants act through three main pharmacological pathways:
| Drug Class | Common Examples | Primary Clinical Use |
|---|---|---|
| Hydantoins | Phenytoin, Fosphenytoin | Focal and generalized tonic-clonic seizures |
| Iminostilbenes | Carbamazepine, Oxcarbazepine | Focal seizures and trigeminal neuralgia |
| Succinimides | Ethosuximide | Absence seizures |
| Valproic Acid derivatives | Sodium valproate, Divalproex | Broad-spectrum (focal and generalized) |
Choosing the right class depends heavily on the specific seizure type, patient age, and potential side effect profiles. Broad-spectrum agents like valproate can manage multiple seizure types, whereas narrow-spectrum drugs like ethosuximide have very specific targets. Misclassifying the seizure type and prescribing the wrong medication can actually worsen seizure frequency.
Anticonvulsants often have narrow therapeutic windows, meaning the concentration range where the drug is safe and effective is very small. If the blood level is too low, seizures return; if it is too high, toxicity occurs.
Oral administration requires strict adherence to scheduled timings to maintain steady plasma levels. Intravenous phenytoin must be given slowly and diluted in normal saline because rapid administration causes severe hypotension and cardiac arrhythmias. It also precipitates easily in dextrose solutions. Routine therapeutic drug monitoring helps clinicians adjust dosages safely, particularly for medications with nonlinear pharmacokinetics like phenytoin, where small dose increases trigger disproportionately large jumps in blood concentration.
Most anticonvulsants cause central nervous system depression, leading to common side effects like drowsiness, dizziness, ataxia, and blurred vision during the initial phase of treatment. These effects often subside as the body builds tolerance.
Long-term use carries unique risks:
Toxicity management focuses on supportive care, maintaining airway patency, and in severe overdoses, activated charcoal or hemodialysis to clear the drug.
Anticonvulsants are notorious for altering liver metabolism through enzyme induction or inhibition. Medications like carbamazepine, phenytoin, and phenobarbital are potent hepatic enzyme inducers. They speed up the breakdown of other drugs, such as oral contraceptives, warfarin, and corticosteroids, rendering them less effective and increasing the risk of unintended pregnancies or blood clots.
Conversely, drugs like valproic acid are enzyme inhibitors, which can cause levels of co-administered drugs to rise to toxic levels. Alcohol and other central nervous system depressants must be avoided because they compound sedation and respiratory depression. Contraindications typically include known hypersensitivity, severe hepatic impairment, and specific metabolic disorders like porphyria for certain drug classes.
Comprehensive nursing assessment begins with a detailed seizure history, noting frequency, duration, triggers, and the exact description of aura or motor movements. Baseline liver function tests, complete blood counts, and kidney function panels are mandatory before therapy starts, as many anticonvulsants cause hepatotoxicity or blood dyscrasias like agranulocytosis.
During maintenance therapy, nurses must monitor for early signs of toxicity, such as nystagmus, slurred speech, and unsteady gait. Mental status assessments are vital because some patients experience mood changes, depression, or suicidal ideation while taking anti-epileptic drugs. Documenting seizure logs accurately helps the physician determine whether therapeutic drug levels need adjustment.
In Nigeria, managing epilepsy often involves navigating cultural beliefs, stigma, and access challenges in public health facilities. Patients and caregivers must understand that anticonvulsants are maintenance medications that must be taken daily, even when the patient has been seizure-free for months. Stopping medication abruptly is the leading cause of status epilepticus.
Practical education includes advising patients never to double a missed dose and to consult a healthcare provider immediately if supply issues arise. Nurses should guide families on creating a safe environment during a seizure—clearing hard objects, turning the patient on their side to prevent aspiration, and never forcing objects into the mouth. Encouraging open dialogue about traditional remedies helps prevent dangerous herb-drug interactions common in local settings.